type-2-diabetes

Documents about type-2-diabetes

• Chronic Reduction of Fasting Glycaemia With Insulin Glargine Improves First and Second Phase Insulin Secretion in Patients With Type 2 Diabetes#18553ClinicalTrials.gov
• How Glargine Insulin, Oral Diabetes Medications and Exenatide May Improve Blood Sugar Control and Weight Gain in Type 2 Diabetics#18566ClinicalTrials.gov
• Study on Liver Fat Content and Visceral Fat Mass in Overweight and Obese Type 2 Diabetes Patients After Treatment With Basal Insulin#18569ClinicalTrials.gov
• Adding Exenatide to Insulin Therapy for Patients With Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease#18805ClinicalTrials.gov
• Canagliflozin on Liver Inflammation Damage in Type 2 Diabetes Patients With Nonalcoholic Fatty Liver Disease#28553ClinicalTrials.gov
• A Pharmacokinetic Study of MK-0941 After Multiple Daily Doses in Subjects With Type 2 Diabetes (MK-0941-012)(COMPLETED)#28580ClinicalTrials.gov
• INTEGRA Study: Primary Care Intervention in Type 2 Diabetes Patients With Poor Glycaemic Control#136248ClinicalTrials.gov
• Evaluation of Efficacy and Safety of Combination Therapy of Henagliflozin Proline, Retagliptin and Metformin in New Diagnosed Type 2 Diabetes Patients#136272ClinicalTrials.gov
• GIP/GLP-1 Co-Activity in Subjects With Overweight and Type 2 Diabetes: Lowering of Food Intake#136273ClinicalTrials.gov
• Effect of Oral Combination Therapy in a Single Dosage Form in Patients With Type 2 Diabetes Mellitus#143779ClinicalTrials.gov
• A Phase 3 Study to Evaluate Efficacy and Safety of HDM1002 Tablets in Adults With Type 2 Diabetes Mellitus#143811ClinicalTrials.gov
• A Phase III Study of BMS-512148 (Dapagliflozin) in Asian Patients With Type 2 Diabetes Who Are Not Well Controlled With Diet and Exercise#143818ClinicalTrials.gov
• A Titration Study of a Glucagon-Like Peptide-1 (GLP-1) Analogue in Patients With Type 2 Diabetes Treated With Metformin.#146399ClinicalTrials.gov
• A Phase 2b Study of DIO-902 or DIO-902 Placebo in Addition to Metformin and Atorvastatin or Atorvastatin Placebo for Type 2 Diabetes#158180ClinicalTrials.gov
• A Study to Evaluate the Effect of Maridebart Cafraglutide on Insulin Sensitivity and β-cell Function in Participants With Type 2 Diabetes Mellitus#162409ClinicalTrials.gov
• A Study of the Co-administration of Sitagliptin and Atorvastatin in Inadequately Controlled Type 2 Diabetes Mellitus (MK-0431E-211)#162416ClinicalTrials.gov
• Investigation of the Effect of Web-based Education on Self-Care Management and Family Support in Women With Type 2 Diabetes#171301ClinicalTrials.gov
• The Effect of Whey Protein Consumed as a Pre-meal on Postprandial Lipemia in Healthy and Subjects With Type 2 Diabetes#172437ClinicalTrials.gov
• Pharmacodynamic Effects of Lixisenatide Compared to Liraglutide in Patients With Type 2 Diabetes Not Adequately Controlled With Insulin Glargine With or Without Metformin#172524ClinicalTrials.gov
• Study Of Safety And Efficacy Of Ertugliflozin (PF-04971729, MK-8835) In Participants With Type 2 Diabetes (MK-8835-016)#184770ClinicalTrials.gov
• Efficacy and Safety of Semaglutide Once-weekly Versus Sitagliptin Once-daily as add-on to Metformin in Subjects With Type 2 Diabetes (SUSTAIN - CHINA MRCT)#18556ClinicalTrials.gov
• Effect of Repaglinide and Metformin Combination Tablet or Rosiglitazone and Metformin in Fixed Dose Combination on Blood Glucose Control in Patients With Type 2 Diabetes#28552ClinicalTrials.gov
• Community Health Worker-Led Postpartum Diabetes Screening#172485ClinicalTrials.gov
• A Study to Evaluate Combining Metformin With Muraglitazar or Pioglitazone in Type 2 Diabetics#136292ClinicalTrials.gov
• Effect of Different Insulin Administrations, All in Combination With Metformin, on Glycaemic Control in Subjects With Type 2 Diabetes Inadequately Controlled by Oral Anti-diabetic Drugs#158166ClinicalTrials.gov
• Lantus Versus Humalog Mix as add-on Therapy in Type Diabetes Patients Failing Sulfonylurea and Metformin Combination Treatment#154877ClinicalTrials.gov
• Determination of the Optimum Cut-off Value of Type 2 Diabetes Diagnosis Among Chinese Population(SENSIBLE STUDY II)#175064ClinicalTrials.gov
• Accuracy of Dexcom G6® and FreeStyle Libre® Sensors in Standardized Hypoxemia Conditions#180292ClinicalTrials.gov
• Assessing the Value of Avocados on Glycemic Control in Type 2 Diabetes#18820ClinicalTrials.gov
• Cardiovascular Outcomes Following Ertugliflozin Treatment in Type 2 Diabetes Mellitus Participants With Vascular Disease, The VERTIS CV Study (MK-8835-004)#127827ClinicalTrials.gov
• A Study of the Effects of Canagliflozin (JNJ-28431754) on Renal Endpoints in Adult Participants With Type 2 Diabetes Mellitus#136218ClinicalTrials.gov
• A Safety and Efficacy Study of Canagliflozin in Older Patients (55 to 80 Years of Age) With Type 2 Diabetes Mellitus#136297ClinicalTrials.gov
• A Study of Tirzepatide (LY3298176) Versus Placebo in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine With or Without Metformin#143783ClinicalTrials.gov
• Long-Term Effects of Insulin Plus Metformin Regimens on the Overall and Postprandial Glycemic Control of Patients With Type 2 Diabetes#146427ClinicalTrials.gov
• The PK/PD, Efficacy, Safety and Tolerability Study of SHR3824 in Combination With Metformin in Type 2 Diabetes Mellitus Patients#152369ClinicalTrials.gov
• Phase III Trial of SGLT2 Inhibitor and Thiazolidinedione Fixed-Dose Combination vs. Monotherapy in Type 2 Diabetes Patients on Metformin#152385ClinicalTrials.gov
• GLP-1 Receptor Agonist Lixisenatide (Morning or Evening) in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Metformin#154871ClinicalTrials.gov
• The Effect of Alogliptin on Pulmonary Function in Obese Patients With Type 2 Diabetes Inadequately Controlled by Metformin Monotherapy#162428ClinicalTrials.gov
• A Study of Aleglitazar in Combination With Metformin in Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With Metformin Monotherapy#172534ClinicalTrials.gov
• Efficacy of Fixed Combination Therapy of Vildagliptin and Metformin Compared to the Individual Monotherapy Components in Drug Naive Patients With Type 2 Diabetes#180325ClinicalTrials.gov
• The Impact of Initiating/Switching to Insulin Detemir on Emotional Well-being and Treatment Satisfaction#123654ClinicalTrials.gov
• 24-Hour Glycemia: Rosiglitazone Versus Glimepiride In Type 2 Diabetes#121281ClinicalTrials.gov
• Study of Ro 205-2349 in Patients With Type 2 Diabetes Mellitus#127764ClinicalTrials.gov
• A Two Part Study of Peroral Insulin in Type 2 Diabetes#146426ClinicalTrials.gov
• Ezetimibe and Simvastatin in Dyslipidemia of Diabetes#148667ClinicalTrials.gov
• Finding the Patient's Voice Diabetes Prevention Programs#180308ClinicalTrials.gov
• The Copenhagen Insulin and Metformin Therapy Trial#184766ClinicalTrials.gov
• CGM in Acute Ischemic Stroke#195503ClinicalTrials.gov
• Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results#18777ClinicalTrials.gov
• Evaluating the Impact of Year Long, Augmented Diabetes Self Management Support#126054ClinicalTrials.gov